MOLOGEN AG: Consortium successfully concludes preclinical development of DNA vaccine against ...
12:33 EDT 26 Jun 2012 | LaMerie
- Expert panel confirms positive results
- Planning for phase I clinical studies begins
Original Article: MOLOGEN AG: Consortium successfully concludes preclinical development of DNA vaccine against ...
More From BioPortfolio on "MOLOGEN AG: Consortium successfully concludes preclinical development of DNA vaccine against ..."
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
